Video

Terrill Jordan Discusses Making Refinements in Year 2 of OCM

Year 2 of the Oncology Care Model is about learning from the lessons of year 1 and extending implementation that has already been started, said Terrill Jordan, CEO of Regional Cancer Care Associates.

Year 2 of the Oncology Care Model (OCM) is about learning from the lessons of year 1 and extending implementation that has already been started, said Terrill Jordan, CEO of Regional Cancer Care Associates.

Transcript

In terms of next steps, what does year 2 of OCM hold for you?

Year 2 is about extending the implementation that we’ve already started. So we’ve learned a lot over that year. We learned to prioritize a little bit more in terms of the data we need and how we prioritize the data as we deliver it to our clinicians. The education process, we’ve learned a little bit more about how we should structure the education process for our clinicians. So we’ve worked a lot on that. We’re looking at the workflow and how we can handle the workflow a little bit differently. We get the feedback now, the feedback loop is taking place. We’re learning what we didn’t do so well, we are learning what worked.

And our clinicians, I think, are a big change, our clinicians are engaging now in a way that they didn’t engage at the start. While they were intellectually engaged, they weren’t emotionally engaged. Now we are seeing emotional engagement. It’s that refining process that is starting to take place.

Related Videos
Kimberly Westrich, MA, chief strategy officer, NPC
Marla Black Morgan, MD, Phoebe Neurology Associates
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo